Ayr Wellness (OTCMKTS:AYRWF – Free Report) had its target price cut by Roth Mkm from $3.50 to $3.00 in a research note released on Thursday,Benzinga reports. They currently have a buy rating on the stock.
Separately, Roth Capital raised Ayr Wellness to a “strong-buy” rating in a research report on Friday, November 8th.
Get Our Latest Report on Ayr Wellness
Ayr Wellness Price Performance
About Ayr Wellness
Ayr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names.
Recommended Stories
- Five stocks we like better than Ayr Wellness
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- How to Invest in Blue Chip Stocks
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Industrial Products Stocks Investing
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Ayr Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayr Wellness and related companies with MarketBeat.com's FREE daily email newsletter.